Enjoy complimentary customisation on priority with our Enterprise License!
The microbiology testing market sie is estimated to grow at a CAGR of 9.98% between 2022 and 2027. The microbiology testing market size is forecast to increase by USD 3,012.8 million. The growth of the market depends on several factors, including the increasing incidence of infectious diseases and cancer, increasing initiatives for rapid diagnostics of infectious diseases, and rising demand for analytical instruments in the food and beverage industries.
This market research report extensively covers market segmentation by method (traditional, rapid, and molecular), product (consumable and instruments), end-user (hospitals and diagnostic laboratories, pharmaceutical and biotechnology companies, and others), and geography (North America, Europe, Asia, and Rest of World). It also includes an in-depth analysis of drivers, trends, and challenges. Furthermore, the report includes historic market data from 2017 to 2021.
To learn more about this report, Download microbiology testing Market Research Report Sample PDF
The increasing incidence of infectious diseases and cancer is notably driving the market growth, although factors such as inadequate healthcare services in developing regions may impede the market growth. Our researchers analyzed the data with 2022 as the base year and the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.
The increasing incidence of infectious diseases and cancer is notably driving market growth. The prevalence of infectious diseases such as tuberculosis, HIV, pneumonia, and malaria has increased. Diseases like HIV attacks eventually destroy the immune system, resulting in AIDS, although this progression takes years. Thus, the body cannot defend itself against germs and infections as the immune system is compromised.
There has been an increase in awareness programs related to infectious diseases such as HIV, cancer, tuberculosis, and pneumonia to encourage preventive healthcare or early diagnosis for improved treatment outcomes. For instance, the Aid for AIDS program understands the needs of patients and provides them with the required treatments and tools to lead normal lives. With the global burden of these diseases increasing, the demand for rapid microbiology techniques for faster and more accurate microbial screening, identification, and testing against pathogens is expected to grow significantly. Such factors will boost the market during the forecast period.
The rise in food safety concerns is an emerging trend in the market. Food products are made up of plants and animals, and they usually contain a variety of microorganisms. Microbes from natural sources may come in contact with and contaminate food during manufacturing and consumption processes. Furthermore, microbial contamination of food items causes spoilage, which can result in foodborne illnesses if consumed. Foodborne illnesses are regarded as serious public health issues around the world. To limit harmful infectious disease growth, microbial identification products and services are used to inspect the quality of newly released food products.
The importance of food safety as a measure to prevent the spread of diseases is growing. In many countries, the government is significantly focusing on food-related safety standards. Regulatory authorities are also constantly updating food safety regulations to ensure that the food and beverage industries deliver the optimum safety and quality of food products to consumers. Thus, owing to such factors the global market is expected to witness growth during the forecast period.
Inadequate healthcare services in developing regions is a major challenge impeding market growth. Many people in several developing regions do not have the required knowledge or access to healthcare facilities to stay healthy. Also, the lack of financial resources is a major obstacle to public health, leading to an increase in infectious diseases, which is a significant public health concern. Moreover, healthcare systems in most developing countries are plagued by the lack of skilled personnel, making it difficult for them to provide access to quality healthcare services such as microbiology testing.
Countries such as Afghanistan and Bangladesh are grappling with the lack of technology and the appropriate policies to enable the delivery of healthcare services. The stigma or misconception about the gravity of conditions such as STDs further discourages any form of testing, including microbiology testing and the subsequent treatment of infectious diseases. Hence, the abovementioned factors will hinder the growth of the market during the forecast period.
Key Microbiology Testing Market Customer Landscape
The microbiology testing market report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.
Global Microbiology Testing Market Customer Landscape
Vendors are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.
Institut Merieux - The company operates under one segment. The company under this segment develops new approaches in the fields of diagnostics, immunotherapy, food safety, and nutrition. The key offerings of the company include microbiology testing solutions.
The market research report also includes detailed analyses of the competitive landscape of the market and information about 15 market vendors, including:
Qualitative and quantitative analysis of vendors has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize vendors as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize vendors as dominant, leading, robust, tentative, and weak.
The market share growth by the traditional segment will be significant during the forecast period. Microscopy, antigen detection, serology, and culture are typically used in traditional or conventional microbiology testing.
Get a glance at the market contribution of various segments Request Market Research Report Sample pdf
The traditional segment was valued at USD 2,276.13 million in 2017 and continued to grow until 2021. Microscopy typically provides a presumptive diagnosis that needs to be confirmed with additional testing modalities, despite the fact that in many situations, it may serve as the gold standard for diagnosis, such as with malaria or stool parasites. Monoclonal antibodies targeted against particular antigens are typically used in antigen detection techniques, and modalities include ELISA and tagged immune microscopy. Furthermore, the foundation of serology testing is the identification of an infection-related host humoral response. This can be extremely specific in some circumstances, whereas in others, cross-reactivity and nonspecific antibodies lead to high rates of false positives. Culture is the main tool used in traditional testing. Clinical specimens are inoculated on various media and then incubated in the case of bacteria and fungi. Utilizing selective and differentiating media may enable improved identification and point toward a possible diagnosis. Typically, species identification is followed by biochemical testing, and antimicrobial susceptibilities are assessed using plating or broth dilution. In general, cultures that are positive signify a gold standard diagnosis. Such benefits are expected to drive the market growth of the traditional method segment of the global market during the forecast period.
For more insights on the market share of various regions Request Market Research Report Sample pdf
North America is estimated to contribute 38% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.
North America was the largest revenue contributor to the global market in 2022. The growing focus on drug and vaccine discovery and development, recent advances in biotechnology and pharmaceutical research, and the presence of several vendors in the country offering a wide range of microbiology testing products are aiding the growth of the market. The market in North America is led by the US and Canada owing to the increase in focus on drug discovery and development. R&D for drug development and diagnosis of diseases requires microbiology testing. The drug discovery market is expected to grow owing to the emergence of new fatal diseases, the high prevalence of infectious diseases such as respiratory infections and sexually transmitted diseases, and the increased demand for personalized medicines. Therefore, the increase in emphasis on the production of drugs has played a major role in the adoption of microbiology testing in the region.
In 2020, the COVID-19 pandemic negatively impacted the market in the region. However, in 2021, business and industrial activities resumed with the lifting of stringent lockdown restrictions owing to the availability of COVID-19 vaccines and the vaccination drives carried out by the governments of different countries. This resulted in the resumption of microbiology testing operations in clinics and hospitals, which has further increased the demand for microbiology testing. Furthermore, the rise in various diseases among the population, such as infectious diseases, has been a major factor driving market growth and expansion. Such elements will fuel the growth of the regional market during the forecast period.
The report forecasts market growth by revenue at global, regional & country levels and provides an analysis of the latest trends and growth opportunities from 2017 to 2027.
Microbiology Testing Market Scope |
|
Report Coverage |
Details |
Page number |
189 |
Base year |
2022 |
Historic period |
2017-2021 |
Forecast period |
2023-2027 |
Growth momentum & CAGR |
Accelerate at a CAGR of 9.98% |
Market growth 2023-2027 |
USD 3,012.8 million |
Market structure |
Fragmented |
YoY growth 2022-2023(%) |
9.51 |
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
Performing market contribution |
North America at 38% |
Key countries |
US, Canada, Germany, UK, and China |
Competitive landscape |
Leading Vendors, Market Positioning of Vendors, Competitive Strategies, and Industry Risks |
Key companies profiled |
Abbott Laboratories, Agilent Technologies Inc., Becton Dickinson and Co., Bio Rad Laboratories Inc., Bruker Corp., Charles River Laboratories International Inc., Creative Diagnostics, Danaher Corp., Don Whitley Scientific Ltd., Euroclone SpA, F. Hoffmann La Roche Ltd., Hologic Inc., Institut Merieux, Kypha Inc., Liofilchem Srl, Merck KGaA, Neogen Corp., Sartorius AG, Shimadzu Corp., and Thermo Fisher Scientific Inc. |
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and Market condition analysis for the forecast period. |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
Request Market Research Report Sample pdf
We can help! Our analysts can customize this market research report to meet your requirements. Get in touch
Get lifetime access to our
Technavio Insights
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.